Clinical features and therapy of medication overuse headache

European Journal of Medical Research

Volumn 9, Issue 12, 2004, Pages 565-569

  Kavuk, Ilker ^a,b   Katsarava, Z ^a   Selekler, M ^c   Sayar, K ^d   Agelink, M W ^b   Limmroth, V ^a   Diener, H C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c KOCAELI UNIVERSITY   (Turkey)

^d Bakirkoy State Teaching and Research Hospital for Psychiatry and Neurology   (Turkey)

Author keywords

Clinical features; Epidemiology; Medication overuse headache; Therapy

Indexed keywords

HEADACHE AND FACIAL PAIN; HUMAN; MIGRAINE; PREVALENCE; PROGNOSIS; REVIEW;

HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; PREVALENCE; PROGNOSIS;

EID: 17844389084     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kavuk I, Katsarava Z, Diener HC. Epidemiology of headache. In: Diener HC (ed) The headaches. 1st ed. Stuttgart: Thieme, 2003: pp. 10-16.
2. Kavuk I, Yavuz A, Cetindere Ü, Agelink MW, Diener HC. Epidemiology of Chronic Daily Headache. Eur J Med Res 2003;8:236-240.
3. Kavuk I, Katsarava Z, Stang A, Agelink MW, Diener HC. New recent information about the epidemiology of headache. Fortschr Neurol Psych 2003;71:1-8.
4. Kavuk I, One-Year Prevalence of Chronic Daily Headache in Turkish Immigrants and German Natives. J Neurol 2003;1:I/146-147.
5. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-196.
6. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987;7:15-19.
7. Micieli G, Manzoni GC, Granella F, Martignoni E, Malferrari G, Nappi G. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M (eds) Drug-Induced Headache. Berlin Heidelberg New York, Springer 1988: pp. 20-28.
8. Rapoport A, Stang P, Gutterman DL, Cady R, Markley H, Weeks R, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996; 36:14-19.
9. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular analgesic use? Cephalalgia 2000;20:294 [abstract].
10. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headache de novo? Headache 1988;38:61-62.
11. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. New Engl J Med 1992;327:1109-1114.
12. van Dusseldotp M, Katan MB. Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 1990;300:1558-1559.
13. Fisher MA, Glass S. Butorphanol (Stadol): A study in problems of current drug information and control. Neurology 1997;48:1156-1160.
14. Ziegler DK Opiate und opioid use in patients with refractory headache. Cephalalgia 1994;14:5-10.
15. Saper JR, Jones JM. Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 1986;9:244-256.
16. Fanciullacci M, Alessandri M, Pietrini U, Briccolani-Bandini E, Beatrice S. Long-term ergotamine abuse: effect on adrenergically induced mydriasis. Clin Pharm Ther 1992; 51:302-307.
17. Diener HC, Dahlöf CGH. Headache associated with chronic use of substances. In: Olesen, J., Tfelt-Hansen, P., Welch, K. M. A. (eds) The Headaches, 2nd edition, Lippincott, Williams & Wilkins, Philadelphia 1999: pp. 871-878.
18. Rapoport A, Weeks R, Sheftell F. Analgesic rebound headache: theoretical and practical implications. In: Olesen J, Tfelt-Hansen P, Jensen K (eds) Proceedings Second International Headache Congress, Copenhagen. Copenhagen; 1985: pp. 448-449.
19. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29:510-514.
20. Diener HC, Bühler K, Dichgans J, Geiselhart S, Gerber WD, Scholz E. Analgetikainduzierter Dauerhopfschmerz. Existiert eine kritische Dosis? Arzneimitteltherapie 1988; 6:156-164.
21. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache 1990;30:634-638.
22. Catarci T, Fiacco F, Argentino C, Sette G, Cerbo R. Ergotamine-induced headache can be-suistained by sumatriptan daily intake. Cephalalgja 1994;14:374-375.
23. Kaube H, May A, Diener HC, Pfaffenrath V. Sumatriptan misuse in daily chronic headache. BMJ 1994;308:1573.
24. Gaist D, Hallas J, Sindrup SH, Gram LF. Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 1996;3:161-165.
25. Gaist D, Tsiropoulus I, Sindrup SH, Hallas J, Rasmussen BK, Kragstrup J. Inappropriate use of sumatriptan: population based register and interview study. Brit J Med 1998; 316:1352-1353.
26. Pini LA, Trend T. Case report.- does chronic use of sumatriptan induce dependence? Headache 1994;34:600-601.
27. Katsarava Z, Fritsche G, Diener HC, Limmroth V. Drug-induced headache (DIH) following the use of different triptans. Cephalalgia 2000;20:293 [abstract].
28. Limmroth V, Kazarawa S, Fritsche G, Diener HC. Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 1999;353:378.
29. Schnider P, Aull S, Baumgartner C, Merterer A, Wöber C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 1996;16:481-485.
30. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A- Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989;236:9-14.
31. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337:1442-1443.
32. Haag G, Baar H, Grotemeyer KH, Pfaffenrath V, Ribbat MJ, Diener HC. Prophylaxe und Therapie des medika-menteninduzierten Dauerkopfschmerzes. Schmerz 1999; 13:52-57.
33. Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open labeled study. Headache 1991;31:71-74.
34. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000;20:107-113.
35. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1990;31:205-209.
36. Mathew NT. Amelioration of ergotamine withdrawal with naproxen. Headache 1987;27:130-133.
37. Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proceed Staff Meet Mayo Clin 1951;26: 153-161.
38. Limmroth V, Katsarava Z. Medication overuse headache. Curr Opin Neurol 2004 junj 7(3):301-6.
39. Fritsche G, Diener HC. Medication overuse headaches - what is new? Expert Opin Drug Saf 2002 Nov;1(4):331-8.
40. Katsarava Z, Diener HC, Limmroth V. Medication over-use headache: a focus on analgesics, ergot alkaloids and triptans. Drug Saf 2001;24(12):921-7.
41. Katsarava Z, Fritsche G. Gordian knot: medication overuse headache. Schmerz 2004 Oct;18(5):421-3.
42. Diener HC, Katasarva Z. Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep 2001 Dec;5(6):545-50.
43. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003 May 27;60(10):1682-3
44. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001;45(4):229-35.
45. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004 Aug,3(8):475-83.
46. Diener HC, Katsafava Z. Medication overuse headache. Curr Med Res Opin 2001;17 Suppl 1:sl7-21.
47. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 (Suppl 7): 1-96.
48. Limmroth V, Kazarawa Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002;59:1011-4.
49. Katsafava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57:1694-8.
50. Manzoni GC, Torelh P for the International Headache Society. IHS classification: new proposals about chronic headache. Neurol Sci 2003;2:86-9.
51. Kavuk I, Yavuz U, Cetindere U, Agelink MW, Diener HC. Chronic headache: A focus on medication overuse. Eur J Med Res 2004;9:1-6.